The first pill to treat postpartum depression is here
Having a baby can be a beautiful experience. Those early weeks with a newborn can be exhausting, but also rewarding.
For some mothers though, this period after birth can be one of the darkest and most difficult times of their lives.
Roughly one in seven people experiences postpartum depression according to the American Psychiatric Association. And one 2019 study found that as many as 50 percent of pregnant people with postpartum depression are never diagnosed.
There’s been only one medication specifically made to treat postpartum depression. An infusion that costs 34,000 dollars.
But last week, the FDA approved the second-ever postpartum treatment and the first-ever postpartum pill. Doctors hope this will be a more accessible option that will also raise awareness about the condition.
We speak to two of the principal investigators on the drug trial about what this new pill means for the future of postpartum treatment.
Copyright 2023 WAMU 88.5